Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Aliskiren fumarate (substance) |
Is a |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing aliskiren (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing aliskiren and hydrochlorothiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aliskiren- and valsartan-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely aliskiren 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely aliskiren 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing aliskiren and amlodipine and hydrochlorothiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aliskiren (as aliskiren fumarate) 150 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aliskiren 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely aliskiren 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely aliskiren 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aliskiren 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aliskiren 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet |
Has basis of strength substance (attribute) |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aliskiren- and valsartan-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing aliskiren in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aliskiren- and hydrochlorothiazide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely aliskiren 150 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely aliskiren 300 milligram and valsartan 320 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely aliskiren 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aliskiren 300 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet |
Has precise active ingredient |
False |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aliskiren fumarate (substance) |
Is modification of (attribute) |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Aliskiren and hydrochlorothiazide only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only aliskiren and valsartan (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only aliskiren and amlodipine and hydrochlorothiazide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only aliskiren (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only aliskiren and hydrochlorothiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only aliskiren and valsartan in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing only aliskiren in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aliskiren (as aliskiren fumarate) 150 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Aliskiren (as aliskiren fumarate) 150 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 12.5 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 25 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Aliskiren (as aliskiren fumarate) 300 mg and amlodipine (as amlodipine besilate) 5 mg and hydrochlorothiazide 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 5 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing only aliskiren and amlodipine and hydrochlorothiazide in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and amlodipine (as amlodipine besilate) 10 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Aliskiren- and amlodipine- and hydrochlorothiazide-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Aliskiren (as aliskiren fumarate) 150 mg and hydrochlorothiazide 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aliskiren (as aliskiren fumarate) 300 mg and hydrochlorothiazide 25 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely aliskiren (as aliskiren fumarate) 300 milligram and hydrochlorothiazide 12.5 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Product containing precisely aliskiren (as aliskiren fumarate) 150 milligram and valsartan 160 milligram/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Aliskiren (as aliskiren fumarate) 300 mg and valsartan 320 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Aliskiren |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |